Study guide
6.2 Non-Adherence Risk Factors
ANCC Gerontological Nursing Certification GERO-BC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the GERO-BC Exam 1.2 Eligibility, Fees, Scoring & Testing 1.3 How to Study for GERO-BC
2 Assessment Tools: Physical & Psychosocial
2.1 Fall, Depression & Pressure-Injury Risk Tools 2.2 Cognitive Assessment Tools (MMSE, MoCA, SLUMS, CAM) 2.3 Functional (ADL/IADL) & Pain Assessment
3 Social Determinants & Care Context
3.1 Social Determinants of Health in Aging 3.2 Caregiver & Support-System Assessment 3.3 Living Environment & Access Barriers
4 Pharmacotherapy Assessment
4.1 Polypharmacy Identification & Medication Review 4.2 Drug Interactions in Older Adults 4.3 Pharmacokinetic Changes with Aging
5 Aging Physiology & Clinical Findings
5.1 Sensory & Neurological Aging Changes 5.2 Circulatory & Cardiopulmonary Aging 5.3 Distinguishing Normal Aging from Pathology
6 Risk Factor Identification
6.1 Cognitive Impairment Risk Recognition 6.2 Non-Adherence Risk Factors 6.3 Elder Abuse & Neglect Screening
7 Evidence-Based Interventions
7.1 Evidence-Based Interventions & Expected Outcomes 7.2 Chronic Disease Management in Older Adults 7.3 Delirium Prevention & Dementia Care 7.4 Depression Care & Palliative/Hospice Care
8 Medications, Beers Criteria & Contraindications
8.1 Beers Criteria Essentials 8.2 Dosage & Route Modifications for Older Adults 8.3 Food, Drug & Herbal Contraindications
9 Care Planning & Prioritization
9.1 Nursing Diagnosis & Problem-List Evaluation 9.2 Person-Centered Care Planning 9.3 Outcome Evaluation & Plan Revision
10 Safety & Therapeutic Environment
10.1 Fall Prevention Interventions 10.2 Restraint Alternatives, Infection Control & Skin Integrity 10.3 Therapeutic Environment & Milieu Management 10.4 Wound Care Essentials for Older Adults
11 Care Coordination Across the Continuum
11.1 Transitions of Care 11.2 Case Management & Community Resources 11.3 Caregiver Support Systems
12 Theories, Prevention & Health Promotion
12.1 Theoretical Frameworks in Gerontology 12.2 Disease Prevention & Screenings 12.3 Immunizations & Preventive Care for Older Adults 12.4 Self-Management & Health Promotion Strategies
13 Communication & Adult Learning
13.1 Principles of Adult Learning 13.2 Communication Barriers & Adaptations 13.3 Patient & Family Education
14 Diversity, Ethics & Legal Practice
14.1 DEI & Older-Adult Subpopulations 14.2 Advance Directives & Surrogate Decision-Making 14.3 Ethics, Advocacy & Scope of Practice 14.4 Capacity & Informed Consent
15 Regulation, QI & Technology
15.1 CMS & Regulatory Compliance 15.2 Quality Improvement in Gerontological Settings 15.3 EHR & Documentation Standards 15.4 Telehealth, Remote Monitoring & Hospital-at-Home
6.2 Non-Adherence Risk Factors
Key Takeaways Explain This Topic AI
Nonadherence is multifactorial—distinguish unintentional barriers (complexity, cost, cognition, sensory limits) from intentional decisions (beliefs, side effects, prioritization)
Polypharmacy, multidose regimens, low health literacy, depression, and inadequate social support are major adherence risk markers in older adults
Assess adherence with nonjudgmental questions, teach-back, regimen review, and pharmacy refill patterns—not accusations of ‘noncompliance’
Interventions must match the barrier: simplify regimens, address cost, use reminders/organizers, involve caregivers, and align therapy with patient goals
Last updated: August 2026
Nonadherence is one of the most common—and most misunderstood—risk factors affecting older adults’ outcomes. For GERO-BC Domain I risk identification ( I-B-2 ), you must recognize who is likely to miss doses, abandon therapies, or follow only part of a plan, then connect that risk to assessment and care planning. Avoid the outdated label “noncompliant,” which implies willful defiance. Nonadherence better reflects a gap between the agreed plan and what happens in real life—usually for understandable reasons.
Why Adherence Risk Is High in Gerontological Practice
Older adults often juggle multiple chronic conditions, specialists, and pharmacies. Aging changes (vision, dexterity, cognition, swallowing), fixed incomes, and caregiver dependence multiply barriers. Missed therapy elevates risk for heart failure exacerbation, stroke, hyperglycemia emergencies, COPD flares, transplant rejection, and preventable hospitalization.
Adherence risk identification is preventive assessment: find the barrier before an adverse event proves it.
Intentional vs Unintentional Nonadherence
Type Definition Typical drivers Nursing implication
Unintentional Person intends to follow the plan but cannot reliably do so Forgetfulness, complex schedules, cost, literacy, sensory/motor limits, no transportation Simplify system; add supports; reduce friction
Intentional Person chooses not to follow some/all of the plan Fear of side effects, disbelief in need, cultural/religious beliefs, preferring “natural” remedies, cost trade-offs framed as choice Explore values; shared decision-making; address fears with education
Mixed Both coexist e.g., skips costly drug intentionally and also forgets evening doses Address both belief and logistics
Clinical pearl: An older adult who “forgets” antihypertensives but never forgets analgesics may be signaling intentional prioritization or side-effect avoidance, not pure memory failure. Ask curiously, not accusingly.
- Major Risk Factor Domains
- 1. Regimen complexity and polypharmacy
Risk rises with:
- Multiple daily dosing times (BID/TID/QID vs once daily)
- Many separate pills versus combination products when appropriate
- “Take with food / take on empty stomach / separate from calcium” rules that conflict
- PRN stacks layered onto scheduled meds
- Frequent regimen changes after hospitalizations without teach-back
Polypharmacy (commonly discussed as ≥5 medications) increases both unintentional errors and intentional rationing. High-risk transitions—hospital discharge, new oxygen, new insulin—deserve intensified adherence risk assessment.
2. Cognitive and sensory barriers
Barrier How it shows up Risk
Mild cognitive impairment / dementia Wrong day in pillbox, double dosing, inability to teach-back Toxicity and undertreatment
- Depression / apathy “I just don’t bother”; abandoned refills Worsening medical and mood outcomes
- Low vision Cannot read labels or syringe markings Dosing errors
- Hearing loss Misses verbal instructions at discharge Incomplete understanding
- Arthritis / tremor / neuropathy Cannot open bottles, split tablets, or inject Skipped doses of essential drugs
- Dysphagia Avoids large tablets Hidden nonadherence
- 3. Health literacy, language, and education gaps
Low health literacy predicts misunderstanding of indication, dose, and warning signs. Limited English proficiency without professional interpreters produces polite nodding without comprehension. Numeric literacy gaps impair insulin titration, warfarin diet teaching, and taper schedules.
Red flags: cannot name medicines or why they are taken; reads label aloud incorrectly; family answers all questions; forms left blank; anxiety when asked to teach-back.
4. Cost and social determinants
Cost-related nonadherence is extremely common on fixed incomes:
- Stretching pills (“every other day”)
- Skipping the “less important” drug (often preventives)
- Choosing food/rent over prescriptions
- Avoiding specialist copays and lab monitoring required for safe therapy
Transportation gaps, rural pharmacy deserts, caregiver unavailability, and unstable housing also sabotage adherence even when motivation is high.
5. Beliefs, culture, side effects, and trust
Intentional nonadherence often follows:
- Prior adverse effects (bleed on anticoagulant, dizziness on antihypertensive, GI upset on metformin)
- Belief that “I feel fine, so I don’t need it”
- Stigma (psychiatric meds, HIV therapy, incontinence drugs)
- Distrust after rushed encounters or conflicting clinician advice
- Preference for herbal products that interact with prescribed drugs
Do not argue first. Elicit the story: What concerns you about this medicine? What happens when you take it? What would make this plan workable for you?
6. Care system and clinician factors
Risk is not only “patient-sided.” Fragmented care, conflicting instructions from multiple prescribers, 15-minute visits, unreadable after-visit summaries, and lack of med reconciliation after discharge create system-generated nonadherence.
Assessing Adherence Risk Without Blame
Use normalizing language:
- “Many people find it hard to take so many medicines. How has it been for you?”
- “In the last week, how many doses do you think you missed?”
- “Which medicines feel most important to you—and which cause problems?”
- Practical assessment methods
- Method Strength Caution
- Nonjudgmental interview Reveals beliefs and barriers Social desirability bias
- Teach-back Tests understanding, not just agreement Literacy and hearing must be supported
- Pillbox review / brown-bag Shows actual regimen in use May miss discarded meds
- Pharmacy refill history Objective gaps over time Auto-refills can mask non-ingestion
- Clinical markers BP, A1C, INR, drug levels Many confounders; not proof alone
- Caregiver report Critical in cognitive impairment Caregiver may over- or under-estimate
Screen for depression, cognition, and SDOH whenever adherence repeatedly fails. Persistent “nonadherence” is an assessment failure until barriers are mapped.
Barrier-Matched Interventions
Risk identification should drive specific interventions:
Complexity — deprescribe when safe; align dosing times; once-daily options; blister packs; combination pills if appropriate.
Forgetfulness — pill organizers, phone alarms, med sync to one pharmacy pickup day, caregiver cueing.
Cost — 90-day supplies, formulary alternatives, discount programs, social work/pharmacy assistance; never assume Medicare Part D eliminates gaps.
Literacy/language — plain language, teach-back, teach-to-goal, professional interpreter, pictogram schedules.
Sensory/motor — large-print labels, easy-open caps (when safe), liquid/crushable forms if appropriate, OT for adaptive devices.
Beliefs/side effects — shared decisions, address myths, adjust agents causing harm, document informed refusal when capacity is intact.
Cognition — simplify to essential meds; supervised administration; home health; locked storage if diversion/double-dosing risk.
Transitions — discharge med reconciliation with teach-back; follow-up call within days; updated med list to PCP and pharmacy.
Linking adherence risk to safety
Nonadherence risk co-travels with fall risk (skipped antihypertensives then overcatch-up dosing), hypoglycemia (inconsistent insulin/meals), and exploitation (caregiver withholding meds). Document concrete barriers and the plan you initiated.
Exam Focus
Expect items that present unexplained poor control (A1C, BP, INR) and ask for the most likely adherence barrier or the best next assessment question . Choose options that identify cost, complexity, literacy, cognition, or side-effect fear over punitive labels. The correct nursing move matches the barrier rather than simply “re-educating” with the same pamphlet.